We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

OPLN:NYSEOPENLANE, Inc. Analysis

Data as of 2026-04-22 - not real-time

$31.49

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

OPENLANE, Inc. is trading in a bullish technical environment, with price holding above its 20‑day and 50‑day moving averages and the MACD indicating continued upward momentum. However, the RSI has climbed into the high range, suggesting the stock may be overbought in the near term, and volume trends are weakening, which could precede a short‑term correction toward the identified support around $26.3.
Fundamentally, the company is delivering solid top‑line growth of roughly 9% YoY and maintains healthy gross and operating margins, yet it carries a very high debt‑to‑equity ratio and a trailing EPS that remains negative. Forward earnings are projected to turn positive, and analysts have a consensus “buy” rating with price targets clustering in the mid‑$30s, implying modest upside despite a DCF fair‑value estimate that sits well below the current price. The blend of strong market positioning in the digital wholesale‑vehicle space and elevated volatility (over 25% 30‑day) creates a nuanced risk‑reward profile that favors cautious optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • High RSI indicating overbought conditions
  • Decreasing volume trend
  • Proximity to short‑term resistance level

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Positive revenue growth and strong operating margins
  • Forward EPS turning positive with a forward PE around 20
  • Analyst consensus price targets in the mid‑$30s suggesting modest upside

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Strategic position in a growing digital wholesale‑vehicle marketplace
  • Sustained cash flow generation despite high leverage
  • Long‑term industry tailwinds for dealer‑to‑dealer digital platforms

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin9.19%
P/E Ratio20.1
ROE10.20%
ROA4.31%
Debt/Equity153.98
P/B Ratio2.7
Op. Cash Flow$391.9M
Free Cash Flow$179.1M

Technical Analysis

TrendBullish
RSI69.4
Support$26.30
Resistance$32.36
MA 20$29.70
MA 50$28.67
MA 200$27.96
MACDBullish
VolumeDecreasing
Fear & Greed Index86.93

Valuation

Fair Value$12.22
Target Price$33.83
Upside/Downside7.46%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.94
Volatility26.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.